Drug Information

Drug General Information
Drug ID
D0K1UR
Former ID
DNC012665
Drug Name
4-Biphenyl-4-yl-2-(1-propyl-butyl)-1H-imidazole
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527102]
Formula
C22H26N2
Canonical SMILES
CCCC(CCC)C1=NC=C(N1)C2=CC=C(C=C2)C3=CC=CC=C3
InChI
1S/C22H26N2/c1-3-8-20(9-4-2)22-23-16-21(24-22)19-14-12-18(13-15-19)17-10-6-5-7-11-17/h5-7,10-16,20H,3-4,8-9H2,1-2H3,(H,23,24)
InChIKey
VAJCFLBVVHOAAW-UHFFFAOYSA-N
PubChem Compound ID
9923013
Target and Pathway
Target(s) Voltage-gated sodium channel subunit alpha Nav1.3 Target Info Inhibitor [527102]
Sodium channel Target Info Inhibitor [527102]
KEGG Pathway Dopaminergic synapse
Reactome Interaction between L1 and AnkyrinsR-HSA-445095:Interaction between L1 and Ankyrins
References
Ref 527102Bioorg Med Chem Lett. 2004 Jul 5;14(13):3521-3.2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators.
Ref 527102Bioorg Med Chem Lett. 2004 Jul 5;14(13):3521-3.2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.